We are live on ! Find out more
BWP

Barlow Wealth Partners Portfolio holdings

AUM $926M
1-Year Est. Return 20.71%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+20.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$790M
AUM Growth
+$25.3M
Cap. Flow
-$19.3M
Cap. Flow %
-2.44%
Top 10 Hldgs %
39.45%
Holding
155
New
8
Increased
46
Reduced
41
Closed
19

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$16.5M
2
ASML icon
ASML
ASML
+$13M
3
HLI icon
Houlihan Lokey
HLI
+$3.75M
4
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$2.97M
5
V icon
Visa
V
+$1.64M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$18.5M
2
CNR
Core Natural Resources Inc
CNR
+$15.4M
3
ELV icon
Elevance Health
ELV
+$10.5M
4
NVO
Novo Nordisk
NVO
+$8.44M
5
TROW icon
T. Rowe Price
TROW
+$6.21M

Sector Composition

Rank Sector Weight
1 Technology 29.01%
2 Financials 21.79%
3 Communication Services 10.73%
4 Industrials 9.07%
5 Healthcare 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
126
Vanguard FTSE All-World ex-US ETF
VEU
$64.9B
$228K 0.03%
3,971
– –
STZ icon
127
Constellation Brands
STZ
$22.6B
$227K 0.03%
1,257
– –
ORCL icon
128
Oracle
ORCL
$338B
$225K 0.03%
1,424
-1,395
-49% -$248K
MO icon
129
Altria Group
MO
$126B
$223K 0.03%
4,372
-1,502
-26% -$80K
SHEL icon
130
Shell
SHEL
$245B
$217K 0.03%
3,272
– –
PECO icon
131
Phillips Edison & Co
PECO
$5.53B
$212K 0.03%
5,982
-1,347
-18% -$51.3K
MKC icon
132
McCormick & Company Non-Voting
MKC
$14.1B
$212K 0.03%
2,950
-255
-8% -$20K
TMO icon
133
Thermo Fisher Scientific
TMO
$215B
$210K 0.03%
+381
New +$209K
TSCO icon
134
Tractor Supply
TSCO
$16.4B
$207K 0.03%
3,900
– –
HWC icon
135
Hancock Whitney
HWC
$6.21B
$205K 0.03%
+3,450
New +$191K
SYPR icon
136
Sypris Solutions
SYPR
$44.2M
$53.3K 0.01%
25,000
– –
AFL icon
137
Aflac
AFL
$66.1B
– –
-5,126
Closed -$573K
AZN icon
138
AstraZeneca
AZN
$271B
– –
-120,444
Closed -$18.5M
CSCO icon
139
Cisco
CSCO
$456B
– –
-9,329
Closed -$490K
CSX icon
140
CSX Corp
CSX
$93.6B
– –
-9,679
Closed -$326K
DHI icon
141
D.R. Horton
DHI
$41.8B
– –
-1,781
Closed -$330K
DUK icon
142
Duke Energy
DUK
$101B
– –
-2,469
Closed -$272K
EMR icon
143
Emerson Electric
EMR
$82.2B
– –
-2,867
Closed -$323K
EOG icon
144
EOG Resources
EOG
$77.3B
– –
-1,545
Closed -$207K
FAST icon
145
Fastenal
FAST
$54.4B
– –
-13,774
Closed -$482K
HUBB icon
146
Hubbell
HUBB
$24.5B
– –
-1,239
Closed -$543K
IR icon
147
Ingersoll Rand
IR
$33.1B
– –
-2,811
Closed -$281K
NVO
148
Novo Nordisk
NVO
$227B
– –
-71,657
Closed -$8.44M
PAYX icon
149
Paychex
PAYX
$44B
– –
-3,758
Closed -$517K
QCOM icon
150
Qualcomm
QCOM
$168B
– –
-2,325
Closed -$388K
3 4 5
6
7

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
MHIC
Marble Harbor Investment Counsel Boston, Massachusetts $923M AUM 14.09% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
VCAM
Van Cleef Asset Management Beachwood, Ohio $929M AUM 13.28% 1-Year Est. Return
GFG
Goldstone Financial Group Oakbrook Terrace, Illinois $922M AUM 14.34% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return

Barlow Wealth Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Barlow Wealth Partners held 155 positions worth $790M, up 3.3% from $765M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barlow Wealth Partners's Q4 2024 filing shows 8 new, 46 increased, 41 reduced and 19 closed positions. Its largest new stake was Nice: 92,449 shares worth $15.5M. The largest sale was AstraZeneca, an estimated $18.5M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Barlow Wealth Partners's largest Q4 2024 buy was Nice: 92,449 shares worth $15.5M.
  • Barlow Wealth Partners added most to Houlihan Lokey in Q4 2024, an estimated $3.75M increase.
  • Barlow Wealth Partners's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $10.5M.
  • Barlow Wealth Partners fully exited AstraZeneca in Q4 2024, selling an estimated $18.5M.
  • Barlow Wealth Partners's ten largest holdings make up 39% of its $790M portfolio in Q4 2024.
  • Barlow Wealth Partners opened 8 new positions and closed 19 in Q4 2024.
  • Barlow Wealth Partners's portfolio value rose 3.3% quarter-over-quarter to $790M.

Based on Barlow Wealth Partners's 13F filing for Q4 2024, filed 17 Jan 2025.